Penn State researchers have shown that inhibiting the protein VPS34 increases GD2 display on neuroblastoma cell surfaces, ...
TechBio firm WhiteLab Genomics has closed a $26 million Series B round to expand in vivo validation of its AI-designed ...
A new preclinical study reveals that KRAS-mutant gastric adenocarcinoma fosters a TGF-beta-dependent immunosuppressive tumour ...
Researchers at the University of Birmingham have identified the P2X7 receptor as a key driver of neuroinflammation in human ...
Stability problems can derail promising biologics late in development. Bringing high-throughput testing earlier into ...
Researchers at Albert Einstein College of Medicine have identified a cellular recycling pathway whose age-related decline allows senescent 'zombie' cells to evade immune clearance.
A new machine learning-based platform called MALVINA measures bacterial invasion, intracellular accumulation and DNA damage at single-cell resolution, exposing infection dynamics that conventional ...
Insilico Medicine has nominated ISM1354, an AI-designed small-molecule GIPR antagonist, as a preclinical candidate for ...
ELRIG Drug Discovery 2026 returns to ExCeL London for its 20th year, with AI, automation and advanced cell models among the technologies set to feature across the two-day programme.
Dr John Stenson is Product Manager in the Biophysical Characterisation group at Malvern Panalytical, based in the company’s UK headquarters. He holds a PhD in Biochemical Engineering from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results